Master Advanced Gene Editing of iPSCs Using CRISPR/Cas9 in 4 weeks through hands-on, project-based online training with DSTC.
Gene editing using CRISPR/Cas9 has become a revolutionary tool in genetic research, enabling precise modifications at the genome level. Induced pluripotent stem cells (iPSCs), generated from adult cells, hold immense potential for regenerative medicine, disease modeling, and drug discovery. CRISPR/Cas9 allows for the precise targeting and modification of specific genes within iPSCs, enabling the creation of disease models and providing insights into the genetic basis of diseases like neurodegenerative disorders, cancer, and genetic syndromes. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
Gene editing using CRISPR/Cas9 has become a revolutionary tool in genetic research, enabling precise modifications at the genome level. Induced pluripotent stem cells (iPSCs), generated from adult cells, hold immense potential for regenerative medicine, disease modeling, and drug discovery. CRISPR/Cas9 allows for the precise targeting and modification of specific genes within iPSCs, enabling the creation of disease models and providing insights into the genetic basis of diseases like neurodegenerative disorders, cancer, and genetic syndromes.
1. Apply biotechnology methods to authentic research and industry problems.
2. Assemble a documented case study that evidences your applied capability.
β’ Master's and senior undergraduate students specializing in biotechnology
β’ R&D engineers and working professionals applying biotechnology in industry
β’ Academics and educators building research or teaching capacity in biotechnology
β’ A demonstrable biotechnology project for your research or industry portfolio.
β’ A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
β’ Feeder-free maintenance, passaging technique and colony morphology assessment
β’ Pluripotency verification and genomic stability monitoring by karyotype or SNP array
β’ Establishing a baseline before editing so later changes are attributable
β’ PAM constraints and on-target activity scoring
β’ Off-target prediction with Cas-OFFinder and CFD scoring, and the limits of prediction
β’ High-fidelity variants: eSpCas9 and SpCas9-HiFi
β’ When base editing or prime editing is the better tool than a double-strand break
β’ RNP nucleofection versus plasmid and viral delivery in iPSCs
β’ NHEJ knockout versus HDR knock-in: choosing the repair outcome
β’ Donor template design: ssODN versus AAV, homology arm length, silent PAM mutation
β’ Cell-cycle timing and HDR enhancement, with realistic efficiency expectations
β’ Single-cell cloning and surviving the bottleneck: ROCK inhibition and plating density
β’ Editing efficiency deconvolution from Sanger traces using ICE or TIDE
β’ Zygosity determination and detection of large deletions that PCR can miss
β’ NGS amplicon validation of the final clone
β’ Empirical off-target discovery: GUIDE-seq, CIRCLE-seq and DISCOVER-seq
β’ Copy-number and karyotype reassessment after clonal expansion
β’ p53 pathway selection pressure and its implications for edited iPSC lines
β’ Directed differentiation of edited lines to the relevant lineage
β’ Isogenic pairs: designing the comparison so the phenotype is attributable to the edit
β’ Functional assays and phenotype validation
β’ Reporting standards and line registration for reproducibility
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | Benchling |
| Covered Tool / Platform | CRISPOR |
| Covered Tool / Platform | Cas-OFFinder |
| Covered Tool / Platform | SnapGene |
| Covered Tool / Platform | Addgene |
| Covered Tool / Platform | NCBI Primer-BLAST |
Based on 0 scholar submissions
No verified reviews published yet. Be the first to share your academic experience.
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.